Dermata Therapeutics Statistics
Total Valuation
DRMA has a market cap or net worth of $4.83 million. The enterprise value is -$2.12 million.
| Market Cap | 4.83M |
| Enterprise Value | -2.12M |
Important Dates
The last earnings date was Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DRMA has 4.02 million shares outstanding. The number of shares has increased by 550.83% in one year.
| Current Share Class | 4.02M |
| Shares Outstanding | 4.02M |
| Shares Change (YoY) | +550.83% |
| Shares Change (QoQ) | +241.28% |
| Owned by Insiders (%) | 21.01% |
| Owned by Institutions (%) | 5.85% |
| Float | 3.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 48.27 |
| PB Ratio | 0.75 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.09
| Current Ratio | 7.09 |
| Quick Ratio | 6.60 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -103.58% and return on invested capital (ROIC) is -67.09%.
| Return on Equity (ROE) | -103.58% |
| Return on Assets (ROA) | -52.66% |
| Return on Invested Capital (ROIC) | -67.09% |
| Return on Capital Employed (ROCE) | -114.77% |
| Weighted Average Cost of Capital (WACC) | 8.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$789,186 |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.15% in the last 52 weeks. The beta is 0.69, so DRMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -83.15% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 2.51 |
| Relative Strength Index (RSI) | 45.24 |
| Average Volume (20 Days) | 52,107 |
Short Selling Information
The latest short interest is 96,498, so 2.40% of the outstanding shares have been sold short.
| Short Interest | 96,498 |
| Short Previous Month | 114,588 |
| Short % of Shares Out | 2.40% |
| Short % of Float | 3.05% |
| Short Ratio (days to cover) | 1.84 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.36M |
| Pretax Income | -7.10M |
| Net Income | -7.10M |
| EBITDA | n/a |
| EBIT | -7.36M |
| Earnings Per Share (EPS) | -$4.03 |
Balance Sheet
The company has $6.95 million in cash and n/a in debt, with a net cash position of $6.95 million or $1.73 per share.
| Cash & Cash Equivalents | 6.95M |
| Total Debt | n/a |
| Net Cash | 6.95M |
| Net Cash Per Share | $1.73 |
| Equity (Book Value) | 6.41M |
| Book Value Per Share | 1.59 |
| Working Capital | 6.41M |
Cash Flow
| Operating Cash Flow | -8.30M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DRMA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -550.83% |
| Shareholder Yield | -550.83% |
| Earnings Yield | -147.16% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for DRMA is $4.00, which is 233.33% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.00 |
| Price Target Difference | 233.33% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 1, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Aug 1, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |